Glaxosmithkline Pharmaceuticals informs about change in directorate

24 Jul 2018 Evaluate

Pursuant to Regulation 30 and Schedule III (A) (7) of the Listing and Disclosure Requirements Regulations, 2015, Glaxosmithkline Pharmaceuticals has informed that Marc Jones, Non-Executive Director and Rajeshwar R. Bajaaj, Independent Director have ceased to be a Directors of the Company from close of the business hours on 24th July 2018.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2311.50 -68.35 (-2.87%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×